Skip to main content
SpringerLink
Log in

Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The objective of this study was to analyze the predictive significance of different prognostic factors associated with recurrence and metastasis after the radical resection in patients with hepatolithiasis complicated by intrahepatic cholangiocarcinoma (HLA/IHCC). A total of 138 patients with HLA/IHCC admitted during April 2006–April 2009 were selected for this study and they were divided into two groups, with and without recurrence/metastasis. After a radical resection surgery, the patients were followed up for 5 years to monitor the recurrence and/or metastasis. The general and clinical data of the two groups were analyzed to evaluate the relevant risk factors. The study showed that recurrence/metastasis occurred in 48 patients with a rate of 34.8 %. Recurrence in liver accounted for 85.4 % (41 cases), whereas in lung and bone metastases occurred at rates of 8.3 % (4 cases) and 6.3 % (3 cases), respectively. Univariate analysis revealed that CA19-9, tumor diameter, tumor amount, lymphatic metastasis, and AJCC stage of the recurrence/metastasis group were significantly different from those of the non-recurrence/metastasis patients (p < 0.05). The multivariate analysis showed that CA19-9 > 200 U/mL, tumor diameter >5 cm, presence of multiple tumors, lymphatic metastasis, and III–IV AJCC stages were independent risk factors of tumor recurrence and metastasis after the radical surgery (p < 0.05). During the 5 years of follow-up, 65 patients (47.1 %) died, including 31 in the recurrence/metastasis and 34 in the non-recurrence/metastasis groups, accounting for 64.5 % (31/48) and 37.8 % (34/90) of mortality in the two groups, respectively. Thus, the 5-year mortality in the recurrence/metastasis group was significantly higher than that in the non-recurrence/metastasis group (p < 0.05). The CA19-9 antigen, tumor diameter, tumor amount, lymphatic metastasis, and AJCC stage were significantly associated with increased risk of post-resection recurrence and metastasis of HLA/IHCC. The massive lymphadenectomy during the surgery and perioperative control of inflammation decreased the risk of recurrence/metastasis and further improved the disease prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Uenishi, T., Kubo, S., Yamazaki, O., Yamada, T., Sasaki, Y., Nagano, H., & Monden, M. (2008). Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. Journal of Hepatobiliary Pancreatic Surgery, 15(4), 417–422.

    Article  PubMed  Google Scholar 

  2. Tan, J., Tan, Y., Chen, F., Zhu, Y., Leng, J., & Dong, J. (2015). Endoscopic or laparoscopic approach for hepatolithiasis in the era of endoscopy in China. Surgical Endoscopy, 29(1), 154–162. doi:10.1007/s00464-014-3669-5.

    Article  PubMed  Google Scholar 

  3. Kasai, K., Kooka, Y., Suzuki, Y., Suzuki, A., Oikawa, T., Ushio, A., et al. (2014). Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon alpha-2b for advanced intrahepatic cholangiocarcinoma. Annals of Surgical Oncology, 21(11), 3638–3645.

    Article  PubMed  Google Scholar 

  4. Yang, X. Q., Xu, Y. F., Guo, S., Liu, Y., Ning, S. L., Lu, X. F., et al. (2014). Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma. World Journal of Gastroenterology : WJG, 20(14), 4076–4084.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mavros, M. N., Economopoulos, K. P., Alexiou, V. G., & Pawlik, T. M. (2014). Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. JAMA Surgery. doi:10.1001/jamasurg.2013.5137.

    PubMed  Google Scholar 

  6. Chen, M. F., Jan, Y. Y., Hwang, T. L., Jeng, L. B., & Yeh, T. S. (2000). Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma. Digestive Disease Science, 45, 312–316.

    Article  CAS  Google Scholar 

  7. Zhou, Y. M., Yin, Z. F., Yang, J. M., et al. (2008). Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World Journal of Gastroenterology, 14, 632–635.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kuroki, T., Tajima, Y., & Kanematsu, T. (2005). Hepatolithiasis and intrahepatic cholangiocarcinoma: Carcinogenesis based on molecular mechanisms. Journal of Hepatobiliary and Pancreatic Surgery, 12, 463–466.

    Article  Google Scholar 

  9. Lazaridis, K. N., & Gores, G. J. (2005). Cholangiocarcinoma. Gastroenterology, 128, 1655–1667.

    Article  PubMed  Google Scholar 

  10. Tischoff, I., & Tannapfel, A. (2007). Hepatocellular carcinoma and cholangiocarcinoma-different prognosis, pathogenesis and therapy. Zentralblatt für Chirurgie, 2007(132), 300–305.

    Article  Google Scholar 

  11. Nakayama, T., Tsuchikawa, T., Shichinohe, T., Nakamura, T., Ebihara, Y., & Hirano, S. (2014). Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection. World Journal of Surgery, 38(7), 1763–1768.

    Article  PubMed  Google Scholar 

  12. Peycru, T., Hardwigsen, J., Gregoire, E., Barbier, L., Richa, H., Campan, P., & Le Treut, Y. P. (2009). Radical surgery in intrahepatic cholangiocarcinoma. Gastroenterologie Clinique et Biologique, 33(3), 187–193.

    Article  CAS  PubMed  Google Scholar 

  13. Zhang, G. W., Lin, J. H., Qian, J. P., & Zhou, J. (2014). Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma. Journal of Surgical Oncology, 109(5), 494–499.

    Article  PubMed  Google Scholar 

  14. Jiang, K., Su, M., Zhang, W., Zhao, X., Wang, J., Dong, J., & Huang, Z. (2014). Complete radiofrequency ablation of hepatolithiasis-associated cholangiocarcinoma and successful management of post-ablation bronchobiliary fistula. Cell Biochemistry and Biophysics, 68(3), 555–559.

    Article  CAS  PubMed  Google Scholar 

  15. Zhu, Q. D., Zhou, M. T., Zhou, Q. Q., Shi, H. Q., Zhang, Q. Y., & Yu, Z. P. (2014). Diagnosis and surgical treatment of intrahepatic hepatolithiasis combined with cholangiocarcinoma. World Journal of Surgery, 38(8), 2097–2104.

    Article  PubMed  Google Scholar 

  16. Jiang, Z. J., Chen, Y., Wang, W. L., Shen, Y., Zhang, M., Xie, H. Y., et al. (2013). Management hepatolithiasis with operative choledochoscopic FREDDY laser lithotripsy combined with or without hepatectomy. Hepatobiliary & Pancreatic Diseases International, 12(2), 160–164.

    Article  Google Scholar 

  17. Han, S. L., Zhou, H. Z., Cheng, J., et al. (2009). Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma. Asian Journal of Surgery, 32(1), 1–6.

    Article  CAS  PubMed  Google Scholar 

  18. Edge, S. B., & Compton, C. C. (2010). The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology, 17, 1471–1474.

    Article  PubMed  Google Scholar 

  19. Lin, C. C., Lin, P. Y., & Chen, Y. L. (2013). Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications. World Journal of Gastroenterology, 19(3), 375–380.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Yang, T., Lau, W. Y., Lai, E. C., Yang, L. Q., Zhang, J., Yang, G. S., et al. (2010). Hepatectomy for bilateral primary hepatolithiasis: A cohort study. Annals of Surgery, 251(1), 84–90.

    Article  PubMed  Google Scholar 

  21. Takaoka, M., Shimatani, M., Ikeura, T., Koyabu, M., Kusuda, T., Fukata, N., et al. (2009). Diagnostic and therapeutic procedure with a short double-balloon enteroscope and cholangioscopy in a patient with acute cholangitis due to hepatolithiasis. Gastrointestinal Endoscopy, 70(6), 1277–1279.

    Article  PubMed  Google Scholar 

  22. Bellocq, J. P., Michiels, J. F., Egele, C., & Chenard, M. P. (2012). ICC and IHC: Techniques and quality assurance. Lessons from the French external quality assessment trials in IHC. Annales de Pathologie, 32(5 Suppl), S94–S95.

    Article  PubMed  Google Scholar 

  23. Li, H. Y., Zhou, S. J., Li, M., Xiong, D., Singh, A., Guo, Q. X., et al. (2012). Diagnosis and cure experience of hepatolithiasis-associated intrahepatic cholangiocarcinoma in 66 patients. Asian Pacific Journal of Cancer Prevention, 13(2), 725–729.

    Article  CAS  PubMed  Google Scholar 

  24. Luo, H. L., Kang, C. H., Chen, Y. T., Chuang, Y. C., Lee, W. C., Cheng, Y. T., & Chiang, P. H. (2013). Severity of hydronephrosis correlates with tumour invasiveness and urinary bladder recurrence of ureteric cancer. BJU International, 112(4), 489–494.

    Article  PubMed  Google Scholar 

  25. Matsukawa, H., Fujiwara, Y., Satoh, D., Shiozaki, S., Ohno, S., Hamada, M., et al. (2013). Two cases of long-term survival after treatment of recurrent intrahepatic cholangiocarcinoma and intrahepatic metastasis in the remnant liver with repeated hepatectomy. Gan to Kagaku Ryoho Cancer & Chemotherapy, 40(12), 1828–1830.

    Google Scholar 

  26. Fukushima, K., Kido, M., Fukumoto, T., Hori, Y., Kusunoki, N., Tsuchida, S., et al. (2011). A case report of intrahepatic cholangiocarcinoma diagnosed as lung cancer with liver metastasis treated with radiofrequency ablation. Gan to Kagaku Ryoho Cancer & Chemotherapy, 38(12), 2030–2032.

    Google Scholar 

  27. Dechaphunkul, A., Kanngurn, S., Dechsukhum, C., Tanutit, P., Khow-Ean, U., & Sunpaweravong, P. (2010). The significance of galectin-3 immunohistochemistry, clinical characteristics and liver imaging in differentiating intrahepatic cholangiocarcinoma from adenocarcinoma liver metastasis. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet, 93(5), 523–528.

    PubMed  Google Scholar 

  28. Yu, Y., Liao, M., Liu, R., Chen, J., Feng, H., & Fu, Z. (2014). Overexpression of lactate dehydrogenase-A in human intrahepatic cholangiocarcinoma: Its implication for treatment. World Journal of Surgical Oncology, 12, 78.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Dhanasekaran, R., Hemming, A. W., Zendejas, I., George, T., Nelson, D. R., Soldevila-Pico, C., et al. (2013). Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncology Reports, 29(4), 1259–1267.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Perkins, G., Slater, E., Sanders, G., & Prichard, J. (2003). Serum tumor markers. American Family Physician, 68(6), 1075–1082.

    PubMed  Google Scholar 

  31. Goonetilleke, K. S., & Siriwardena, A. K. (2007). Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology, 33(3), 266–270.

    Article  CAS  PubMed  Google Scholar 

  32. Jan, Y. Y., Yeh, C. N., Yeh, T. S., et al. (2005). Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: Two decades of experience at Chang Gung Memorial Hospital. World Journal of Gastroenterology, 11, 1779–1784.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Li, Y. G., & Zhang, N. (2009). Clinical significance of serum tumour M2-pk and CA19-9 detection in the diagnosis of cholangiocarcinoma. Digestive Liver Disease, 44, 605–608.

    Article  Google Scholar 

  34. Lazarov, N., Lazarov, L., & Lazarov, S. (2013). Tumor size and prognosis for patients with epithelial ovarian carcinoma at early stage. Akusherstvo i Ginekologiia, 52(4), 10–12.

    CAS  PubMed  Google Scholar 

  35. Gupta, D., & Lis, G. (2010). CG: Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutrition Journal, 9, 69–84.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Yamamoto, M., Takasaki, K., & Yoshikawa, T. (1999). Lymph node metastasis in intrahepatic cholangiocarcinoma. Japanese Journal of Clinical OncoIogy, 29(3), 147–150.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Liver & Gallbladder Surgery, The First People’s Hospital, Shangqiu, Henan, China

    Yufei Zhu, Yunhai Zhu, Feng Cai & Jie Zhao

  2. Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Jimo Road 150, Shanghai, 200120, China

    Feng Liu

Authors
  1. Yufei Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yunhai Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Feng Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Feng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Feng Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Zhu, Y., Cai, F. et al. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma. Cell Biochem Biophys 73, 455–460 (2015). https://doi.org/10.1007/s12013-015-0665-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-015-0665-x

Keywords

Search

Navigation